MedPath

Effect of product containing Euglena gracilis against constipation. A randomized, double-blind, placebo-controlled, crossover-group trial.

Not Applicable
Recruiting
Conditions
people tend to be constipated
Registration Number
JPRN-UMIN000024130
Lead Sponsor
KSO Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Who meet any of the following conditions will be excluded. 1,Who regularly use intestinal drug and laxatives(including strong laxatives). 2,Who use medicine such as antibiotics that affect digestion and absorption. 3,Who can not stop intake the health food to relieve constipation (including Food for Specified Health Uses (FOSHU)) during the screening period. 4,Who can not stop intake food containing viable bacteria such as Lactic acid bacteria, Bifidobacteria, Natto bacteria and/or enhanced with oligosaccharide, dietary fiber and/or the health food to relieve constipation (including Food for Specified Health Uses (FOSHU)) and/or containing a large amount of sugar alcohol during the screening period. 5, Who habitually consume higher amount of alchole (more than 360mL in terms of Japanese Sake per day). 6, Who can not stop intake food containing Euglena gracilis. 7, Who has chronic malady of digestive organ authorities. 8,Who have allergic to food. 9, Who has a medical history of diseases or surgery affecting digestion, absorption and bowel movement (except for appendicectomy). 10,Who have serious diseases requiring an urgent treatment, or who accept severe complication. 11, Who is pregnant or willing to be pregnant or breast-feeding during this study. 12, Who are participated in another clinical trial that intake/apply any of food, drug, and cosmetics, or willing to be that. 13,Who are judged unsuitable for this study by test responsibility doctor.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath